Clinical toxicities and quality of life measures in patients receiving infusions of T cells armed with OKT3 x anti-Her2 bispecific antibody

W Young,R Rathore,G Colvin,M Falvey, R Grabert, J Jarvis, J Gall,G Elfenbein,L Lum

JOURNAL OF IMMUNOTHERAPY（2003）

Cited 0|Views2

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined